-
A new Alzheimer’s treatment is showing promising initial results in early clinical trials. Published in a study in Nature Medicine, researchers from Western University, Stanford University and the University of California, San Francisco, have evaluated the effectiveness of a drug that is for now called LM11A-31, which targets a specific neurotrophin receptor. According to the […]
-
Entrepreneur and philanthropist Bill Gates believes the healthcare industry is “at a tipping point on Alzheimer’s.” That’s what Gates told Scientific American in a recent interview. Gates noted that, at the beginning of last year, the therapeutic pipeline for Alzheimer’s disease encompassed 187 clinical trials and contained 141 therapeutic drug formulations. Through Gates Ventures, Gates’ […]
-
Sometimes solving challenges in the memory care sector can feel like climbing Mount Everest—just ask Anthem Memory Care CEO Isaac Scott. Like climbing the famous summit, memory care operators have quite a climb ahead of them, in several ways. One big one is the remainder of this year, which will be a test of operational […]
-
Memory care demand is expected to grow in the years ahead – but operators must evolve for the future if they hope to see it. To help attract new residents in the months and years ahead, operators are both focusing on the real estate and the knowledge of treating cognitive decline. That is resulting in […]
-
Brookdale (NYSE: BKD) is in the process of rolling out its HealthPlus to more than 80 additional communities throughout this year. The implementation of the program will have an outsized impact on memory care, according to Kim Elliott, senior vice president and chief nursing officer at Brookdale. Brookdale has deployed HealthPlus in about 50 communities […]
-
A hormone found in the brain of every human could be used as a treatment to delay the proliferation of Alzheimer’s in its early stages. Researchers with the University of Dundee in Scotland found that a small part of an appetite-suppressing hormone known as leptin could reduce the effects of the two harmful proteins in […]
-
By: Lara Unnerstall The pandemic. The “great resignation.” And now, in 2024, a tight labor market. All of these health and economic forces have hit senior living operators hard, with those in memory care feeling the pain both acutely and cumulatively. Unfortunately, the problem isn’t going to go away overnight. Recent projections say many more […]
-
Cedarhurst Senior Living is expanding its memory care programming while creating a new dementia care-focused training program to improve service to older adults living with cognitive decline. Regional directors began overseeing life enrichment departments at its communities, and developed a new memory care training program based on evidence-based dementia research. The four-hour intensive training program […]
-
A new online registry that tracks cases of Alzheimer’s disease and other forms of dementia in Virginia is now enshrined into law in the commonwealth. The Virginia Memory Project, a collaboration between Virginia Commonwealth University and the Virginia Department of Health (VDH), was codified into law on April 2. The project is meant to track […]
-
Behavioral tech platform Rippl has acquired a startup aimed at providing information and services for dementia caregivers in its ongoing quest to broaden and deepen its memory care-related services. Rippl acquired the startup, Kinto, in last month. Terms of the deal were not disclosed. In the coming months, Rippl will integrate technology developed by Kinto […]



